Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitis

Peritoneal Dialysis International

Volumn 32, Issue 5, 2012, Pages 516-524

  Johnson, David W ^a,b   Clayton, Philip ^a,c   Cho, Yeoungjee ^a,b   Badve, Sunil V ^a,b   Hawley, Carmel M ^a,b   McDonald, Stephen ^a,d   Boudville, Neil ^a,e   Wiggins, Kathryn J ^a,f   Bannister, Kym ^a,d   Brown, Fiona ^a,g  

^a Australia and New Zealand Dialysis and Transplant Registry   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f ROYAL MELBOURNE HOSPITAL   (Australia)

^g MONASH MEDICAL CENTRE   (Australia)

Author keywords

After hours; Bacteria; Fungus; Microbiology; Outcomes; Peritonitis; Temporal variation

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CEFAZOLIN; FIBRINOLYTIC AGENT; GENTAMICIN; HEPARIN; VANCOMYCIN;

ADULT; ADVERSE OUTCOME; ARTICLE; BACTERIAL PERITONITIS; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BODY MASS; CATHETER REMOVAL; CORYNEBACTERIUM; DEATH; DIALYSIS CATHETER; DISEASE ASSOCIATION; DRUG EFFICACY; ENTEROCOCCUS; FEMALE; FUNGAL PERITONITIS; FUNGUS; FUNGUS CULTURE; FUNGUS IDENTIFICATION; GRAM NEGATIVE BACTERIUM; HEALTH CARE FACILITY; HEMODIALYSIS; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NONHUMAN; PERIODICITY; PERITONEAL DIALYSIS; PERITONITIS; PREDICTION; PRIORITY JOURNAL; PSEUDOMONAS; RELAPSE; RESIDENTIAL AREA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; WEEKDAY; WEEKEND;

AFTER-HOURS CARE; ANTI-BACTERIAL AGENTS; AUSTRALIA; FEMALE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEW ZEALAND; PERITONEAL DIALYSIS; PERITONITIS; PROGNOSIS; REGISTRIES; SURVIVAL RATE; TIME FACTORS;

EID: 84866443838     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2011.00169     Document Type: Article

References (20)

1. Wong HJ, Morra D. Excellent hospital care for all: open and operating 24/7. J Gen Intern Med 2011; 26:1050-2.
2. Kostis WJ, Demissie K, Marcella SW, Shao YH, Wilson AC, Moreyra AE. Weekend versus weekday admission and mortality from myocardial infarction. N Engl J Med 2007; 356:1099-109.
3. Bell CM, Redelmeier DA. Mortality among patients admitted to hospitals on weekends as compared with weekdays. N J Med 2001; 345:663-8. [Erratum in: N J Med 2001; 345:1580]
4. Becker DJ. Weekend hospitalization and mortality: a critical review. expert Rev Pharmacoecon outcomes Res 2008; 8:23-6.
5. Ghali JR, Bannister KM, Brown FG, Rosman JB, Wiggins KJ, Johnson DW, et al. Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int 2011; 31:651-62.
6. Barraclough K, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes. Am J Kidney Dis 2010; 55:121-31.
7. Barraclough K, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases. Nephrol Dial Transplant 2009; 24:3834-9.
8. Edey M, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 cases. Nephrol Dial Transplant 2010; 25:1272-8.
9. Fahim M, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Coagulase negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases. Nephrol Dial Transplant 2010; 25:3386-92.
10. Fahim M, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases. Am J Kidney Dis 2010; 55:690-7.
11. Govindarajulu S, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Perit Dial Int 2009; 30:311-19.
12. Jarvis EM, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Predictors, treatment, and outcomes of non-Pseudomonas gram-negative peritonitis. Kidney Int 2010; 78:408-14.
13. Jose MD, Johnson DW, Mudge DW, Tranæus A, Voss D, Walker R, et al. Peritoneal dialysis practice in Australia and New Zealand: a call to action. Nephrology (Carlton) 2011; 16:19-29.
14. Miles R, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int 2009; 76:622-8.
15. O'Shea S, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases. BMC Nephrol 2009; 10:19.
16. Siva B, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol 2009; 4:957-64.
17. Johnson DW, Dent H, Hawley CM, McDonald SP, Rosman JB, Brown FG, et al. Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Am J Kidney Dis 2009; 53:290-7.
18. Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, et al. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 2010; 30:393-423.
19. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25:107-31.
20. Piraino B, Bernardini J, Brown E, Figueiredo A, Johnson DW, Lye WC, et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int 2011; 31:614-30.